Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tocira 400mg Infusion

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Tocilizumab (400mg)

Overview Tocira 400mg Infusion

Infliximab 400mg intravenous solution treats diverse inflammatory disorders affecting joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis, Crohn's disease). Its mechanism involves TNF-alpha inhibition, reducing inflammation. Administered solely by healthcare providers, this infusion requires consistent daily use for optimal efficacy. Continue the prescribed regimen, completing the full course even with symptom improvement. Common adverse reactions include headache, hypertension, upper respiratory infections, elevated liver enzymes, and nasopharyngitis. Report persistent or bothersome side effects to your physician, who can offer management strategies. Increased infection susceptibility is possible; promptly report fever, cough, rash, diarrhea, or flu-like symptoms. Prior to treatment, disclose any cardiac, renal, or hepatic issues, and provide a complete medication list. Regular blood tests will monitor your blood cell counts throughout treatment. Pregnant or breastfeeding individuals should consult their doctor before initiating treatment.

Primary Ingredients of Tocira 400mg Infusion

No information provided. Please provide the text you wish me to rephrase.

Uses of Tocira 400mg Infusion

Management strategies for ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease.

Major Benefits of Tocira 400mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is not advised.

Common Side effects of Tocira 400mg Infusion:

  • Headache
  • High blood pressure
  • Upper respiratory tract infection
  • Injection site reactions (pain, swelling, redness)

How to use Tocira 400mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Tocira 400mg Infusion works:

Tocira 400mg infusion inhibits specific inflammatory mediators, thereby alleviating the swelling, redness, and inflammation characteristic of some arthritic conditions.

SAFETY ADVICE

AlcoholAlcoholSAFE

Tocira 400mg Infusion does not interact negatively with alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Tocira 400mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Infusion of Tocira 400mg is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Administering Tocira 400mg intravenously can induce drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects manifest.

KidneyKidneyCAUTION

The administration of 400mg Tocira infusions requires careful consideration in individuals with impaired renal function. Dosage modification of 400mg Tocira infusions may be necessary. Physician consultation is advised. Data regarding the use of 400mg Tocira infusions in patients exhibiting moderate to severe kidney disease is limited. Dosage alteration is not indicated for patients with mildly compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should receive Tocira 400mg Infusion cautiously, potentially requiring dose modification. Physician consultation is advised. Tocira 400mg Infusion is contraindicated in individuals experiencing active liver disease.

What if you forget to take Tocira 400mg Infusion :

Should you forget a scheduled Tocira 400mg infusion, contact your physician for guidance.

Facts to Know About Tocira 400mg Infusion

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Action Category Biologic Disease-Modifying Antirheumatic Drugs (DMARDs)

FAQs on Tocira 400mg Infusion

Tocilizumab 400mg infusion is indicated for moderate to severe COVID-19 patients with persistent, worsening hypoxia despite 24-48 hours of corticosteroid and supportive therapy.
Tocilizumab 400mg infusion isn't suitable for all COVID-19 patients due to potential adverse effects. It may prolong viral infection and shedding, necessitating careful risk-benefit assessment before administration.
Tocilizumab 400mg infusion may cause serious side effects, including anaphylaxis, elevated liver enzymes (transaminitis), low white blood cell counts (leukopenia and neutropenia, increasing infection risk), and serious bacterial or viral infections, or TB reactivation.
Tocira 400mg Infusion is contraindicated in patients with abnormal liver enzyme levels (transaminitis), platelet counts below 50,000, tuberculosis, or any active bacterial or viral infection. It is also contraindicated during pregnancy and breastfeeding due to the risk of serious complications.
If your condition doesn't improve after Tocira 400mg Infusion, your doctor will determine the next steps. While Tocira 400mg Infusion reduces lung inflammation, it doesn't repair pre-existing damage; full lung recovery takes time. Continued breathlessness warrants further investigation for potential pulmonary (e.g., intravascular coagulopathy) or cardiac issues. Any concurrent bacterial infections require separate treatment.
Tocira 400mg Infusion
35,213